Showing results (2061-2070 of 2,859) with videos related to

Sort By:
Pageof 286
Pathology Oncology Research : POR|August 5, 2022
Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric AdenocarcinomaZhiyi Zhou, Dandan Huang, Shudong Yang, et al.
Pathology Oncology Research : POR|August 8, 2022
The Role of Tumor Microenvironment and Immune Response in Colorectal Cancer Development and PrognosisMaria Wozniakova, Jozef Skarda, Milan Raska
Pathology Oncology Research : POR|February 24, 2023
Cohort size required for prognostic genes analysis of stage II/III esophageal squamous cell carcinomaLinghong Kong, Ming Yang, Zhiyi Wan, et al.
Pathology Oncology Research : POR|February 27, 2023
3D bioprinting and the revolution in experimental cancer model systems-A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structuresDániel Sztankovics, Dorottya Moldvai, Gábor Petővári, et al.
Pathology Oncology Research : POR|August 12, 2021
Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A ReviewYang An, Jiaolin Zhou, Guole Lin, et al.
Pathology Oncology Research : POR|September 9, 2021
GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative StudyDeepali Jain, Prerna Guleria, Varsha Singh, et al.
Pathology Oncology Research : POR|September 9, 2021
Retraction: MiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFARPathology Oncology Research Editorial Office
Pathology Oncology Research : POR|September 13, 2021
Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary MalignancyXi Tian, Wen-Hao Xu, Jun-Long Wu, et al.
Pathology Oncology Research : POR|February 16, 2023
Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinomaYu-Ting Ma, Yan Li, Li Yan, et al.
Pathology Oncology Research : POR|November 5, 2025
Circulating tumor cells: indicators of cancer progression, plasticity and utility for therapiesTamás Richárd Linkner, Zsófia Brigitta Nagy, Alexandra Kalmár, et al.
Pageof 286